185 related articles for article (PubMed ID: 1493435)
1. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.
Galton DA
Leuk Lymphoma; 1992 Aug; 7(5-6):343-50. PubMed ID: 1493435
[TBL] [Abstract][Full Text] [Related]
2. Haematological classification of the chronic myeloid leukaemias.
Shepherd PC; Ganesan TS; Galton DA
Baillieres Clin Haematol; 1987 Dec; 1(4):887-906. PubMed ID: 3332855
[TBL] [Abstract][Full Text] [Related]
3. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick H; Sultan C; Cox C
Br J Haematol; 1994 Aug; 87(4):746-54. PubMed ID: 7986717
[TBL] [Abstract][Full Text] [Related]
4. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?
Oscier DG
Br J Haematol; 1996 Mar; 92(3):582-6. PubMed ID: 8616021
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases.
Costello R; Lafage M; Toiron Y; Brunel V; Sainty D; Arnoulet C; Mozziconacci MJ; Bouabdallah R; Gastaut JA; Maraninchi D
Br J Haematol; 1995 Jun; 90(2):346-52. PubMed ID: 7794755
[TBL] [Abstract][Full Text] [Related]
6. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
7. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
8. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
9. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
Michaux JL; Martiat P
Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
Kvasnicka HM
Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
[TBL] [Abstract][Full Text] [Related]
13. Atypical chronic myeloid leukemias.
Oscier D
Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
[TBL] [Abstract][Full Text] [Related]
14. Monocyte analysis in chronic myelomonocytic leukaemia.
Frew ME; Donaldson K
Br J Biomed Sci; 1997 Dec; 54(4):244-50. PubMed ID: 9624733
[TBL] [Abstract][Full Text] [Related]
15. Update on CML-Like Disorders.
Cross NCP
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S101-S102. PubMed ID: 32862848
[TBL] [Abstract][Full Text] [Related]
16. Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia.
Gow J; Hughes D; Farr C; Hamblin T; Oscier D; Brown R; Padua RA
Leuk Res; 1988; 12(10):805-10. PubMed ID: 3059070
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of chronic granulocytic leukemia.
Spiers AS
Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
[TBL] [Abstract][Full Text] [Related]
18. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
20. Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality.
Benedek D; Kiehl M; Draube A; Chemnitz J; Diehl V; Söhngen D
Leuk Lymphoma; 2000 Aug; 38(5-6):639-44. PubMed ID: 10953987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
